Which has the lower trailing P/E, INCY or UTHR?

INCY has the lower trailing P/E: INCY trades at 15.96 and UTHR at 17.72. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, INCY or UTHR?

Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus UTHR at 14.68%.

Is INCY or UTHR more profitable?

UTHR runs the higher net margin — INCY at 27.71% versus UTHR at 41.56%.

How have INCY and UTHR total returns compared?

Over the past 10 years, INCY delivered 4.38% and UTHR delivered 15.50% annualized total return. Past performance doesn't predict future results.

Incyte Corporation (INCY) vs United Therapeutics Corporation (UTHR)

A side-by-side comparison of Incyte Corporation and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

INCY

Incyte Corporation

$25.40B

$125.31HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT

UTHR

United Therapeutics Corporation

$21.00B

$494.63HealthcareDelayed quote: Sep 18, 2026, 4:00 PM EDT

Total return — INCY vs UTHR

growth of $100 · dividends reinvested · last 10y

INCY +52.8% (+4.3%/yr)UTHR +312.8% (+15.2%/yr)UTHR compounded faster over this window

INCY UTHR

INCY vs UTHR: by the numbers

•INCY is the larger company ($25.40B vs $21.00B market cap).
•INCY trades at the lower trailing earnings multiple (15.96 vs 17.72 P/E), one valuation lens rather than an overall verdict.
•UTHR converts more revenue to profit (41.56% vs 27.71% net margin).
•INCY grew revenue faster over the past five years (16.43% vs 14.68% CAGR).

Metrics side by side

Valuation

Metric	INCY	UTHR
P/E ratio	15.96	17.72
Forward P/E	33.31	18.92
P/S ratio	4.36	6.66
P/B ratio	4.00	3.28
EV / EBITDA	11.08	12.84
FCF yield	7.56%	5.21%

Profitability

Metric	INCY	UTHR
Gross margin	92.62%	86.14%
Operating margin	31.57%	44.49%
Net margin	27.71%	41.56%
ROE	25.41%	20.48%
ROIC	22.95%	17.69%

Growth (annualized)

Metric	INCY	UTHR
Revenue CAGR (5Y)	16.43%	14.68%
EPS CAGR (5Y)	21.19%	20.93%
FCF CAGR (5Y)	33.69%	14.31%
Total return CAGR (5Y)	11.30%	19.17%

Frequently asked

Which has the lower trailing P/E, INCY or UTHR?: INCY has the lower trailing P/E: INCY trades at 15.96 and UTHR at 17.72. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, INCY or UTHR?: Over the past five years, INCY grew revenue faster — INCY at a 16.43% CAGR versus UTHR at 14.68%.
Is INCY or UTHR more profitable?: UTHR runs the higher net margin — INCY at 27.71% versus UTHR at 41.56%.
How have INCY and UTHR total returns compared?: Over the past 10 years, INCY delivered 4.38% and UTHR delivered 15.50% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INCY analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

Incyte P/E ratio United Therapeutics P/E ratio Incyte ROE United Therapeutics ROE Incyte operating margin United Therapeutics operating margin Incyte revenue growth United Therapeutics revenue growth Incyte free cash flow United Therapeutics free cash flow

Incyte & United Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.